Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q6)Mar 31, 2025 | (FY)Sep 30, 2024 | (Q6)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q9)Jun 30, 2023 | (Q6)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q9)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.63%13.97M | -3.25%6.84M | -3.67%14.06M | -1.70%7.07M | 21.43%14.6M | 27.17%10.79M | 35.26%7.19M | 40.09%3.66M | 2.16%12.02M | -2.21%8.49M |
| Operating income | -0.63%13.97M | -3.25%6.84M | -3.67%14.06M | -1.70%7.07M | 21.43%14.6M | 27.17%10.79M | 35.26%7.19M | 40.09%3.66M | 2.16%12.02M | -2.21%8.49M |
| Cost of sales | 1.32%-9.14M | 0.87%-4.53M | 8.00%-9.26M | 12.43%-4.57M | -8.92%-10.06M | -19.10%-7.77M | -27.80%-5.22M | -38.94%-2.72M | -4.00%-9.24M | -1.24%-6.52M |
| Operating expenses | 1.32%-9.14M | 0.87%-4.53M | 8.00%-9.26M | 12.43%-4.57M | -8.92%-10.06M | -19.10%-7.77M | -27.80%-5.22M | -38.94%-2.72M | -4.00%-9.24M | -1.24%-6.52M |
| Gross profit | 0.71%4.84M | -7.62%2.3M | 5.96%4.8M | 26.79%2.49M | 62.98%4.53M | 53.92%3.03M | 60.05%1.97M | 43.53%943K | -3.50%2.78M | -12.15%1.97M |
| Selling expenses | -11.14%-2.1M | -14.44%-1.05M | -8.08%-1.89M | -4.34%-914K | -19.62%-1.74M | -20.81%-1.31M | -23.21%-876K | -22.71%-443K | -2.39%-1.46M | -1.31%-1.08M |
| Administrative expenses | -2.22%-2.03M | -1.18%-1.03M | -1.07%-1.98M | -19.56%-1.02M | -40.57%-1.96M | -28.91%-1.3M | -29.20%-854K | -39.94%-452K | 7.74%-1.4M | 9.98%-1.01M |
| Special items of operating profit | 5.50%115K | 11.90%47K | 230.30%109K | 250.00%42K | -70.27%33K | -51.92%50K | -85.37%12K | -91.67%4K | -48.13%111K | -44.39%104K |
| Operating profit | -20.46%832K | -54.74%272K | 21.35%1.05M | 141.37%601K | 2,055.00%862K | 2,328.57%468K | 508.20%249K | 147.62%52K | -75.16%40K | -108.90%-21K |
| Financing cost | 50.00%-5K | 0.00%-5K | 0.00%-10K | 0.00%-5K | 16.67%-10K | 22.22%-7K | 16.67%-5K | 33.33%-2K | 14.29%-12K | 18.18%-9K |
| Earning before tax | -20.17%827K | -55.20%267K | 21.60%1.04M | 144.26%596K | 2,942.86%852K | 1,636.67%461K | 464.18%244K | 177.78%50K | -80.95%28K | -113.33%-30K |
| Tax | -6.64%-321K | -4.44%-94K | -49.01%-301K | ---90K | -187.07%-202K | ---- | ---- | ---- | 134.34%232K | 266.67%100K |
| After-tax profit from continuing operations | -31.16%506K | -65.81%173K | 13.08%735K | 107.38%506K | 150.00%650K | 558.57%461K | 639.39%244K | 177.78%50K | 5.69%260K | -57.58%70K |
| Earning after tax | -31.16%506K | -65.81%173K | 13.08%735K | 107.38%506K | 150.00%650K | 558.57%461K | 639.39%244K | 177.78%50K | 5.69%260K | -57.58%70K |
| Profit attributable to shareholders | -31.16%506K | -65.81%173K | 13.08%735K | 107.38%506K | 150.00%650K | 558.57%461K | 639.39%244K | 177.78%50K | 5.69%260K | -57.58%70K |
| Basic earnings per share | -33.33%0.0006 | -66.67%0.0002 | 12.50%0.0009 | 100.00%0.0006 | 166.67%0.0008 | 500.00%0.0006 | 0.0003 | 0.0001 | 0.00%0.0003 | -50.00%0.0001 |
| Diluted earnings per share | -33.33%0.0006 | -66.67%0.0002 | 12.50%0.0009 | 100.00%0.0006 | 166.67%0.0008 | 500.00%0.0006 | 0.0003 | 0.0001 | 0.00%0.0003 | -50.00%0.0001 |
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | Foo Kon Tan LLP | -- | Foo Kon Tan LLP | -- | Foo Kon Tan LLP | -- | -- | -- | Foo Kon Tan LLP | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.